What Gilead Is Getting Through The Acquisition Of Arcellx
Source: SeekingAlpha
2026-02-23 11:46:56 ET
M&A is back in the biotech industry. After a disappointing January and almost no activity to date in February, Gilead ( GILD ) brings some joy back with up to $7.8 billion acquisition of partner Arcellx ( ACLX )....
Read the full article on Seeking Alpha
For further details see:
What Gilead Is Getting Through The Acquisition Of Arcellx
Legend Biotech Corporation
NASDAQ: LEGN
LEGN Trading
0.43% G/L:
$18.77 Last:
299,139 Volume:
$19.17 Open:
LEGN Latest News
February 24, 2026 08:00:00 am
Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results
February 20, 2026 04:03:28 pm
HHLR Advisors Fully Exits Baidu as AI Push Tests Its Advertising-Funded Model
January 21, 2026 08:00:00 am
Legend Biotech to Present CARVYKTI® Data at 2026 Tandem Meetings Reinforcing Growing Evidence Supporting Earlier Use
January 12, 2026 08:00:00 am
Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference
LEGN Stock Data
$3,309,357,827
166,569,786
N/A
63
N/A
Biotechnology & Life Sciences
Healthcare
US
Somerset
